William Sharp becomes CEO of ArunA Biomedical
This article was originally published in Scrip
William Sharp has been appointed president and CEO of ArunA Biomedical (US). Mr Sharp succeeds ArunA founder Dr Steven Stice, who will remain as the company's chairman and scientific officer. Previously, Mr Sharp worked for BioProcessors Corporation, Gentra Systems and Cellomics. He has also been added to ArunA's board of directors.